198 related articles for article (PubMed ID: 33383413)
1. Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.
Vandewal A; Delbecque K; Van Rompuy AS; Noel JC; Marbaix E; Delvenne P; Nisolle M; Van Nieuwenhuysen E; Kridelka F; Vergote I; Goffin F; Han SN
Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():95-99. PubMed ID: 33383413
[TBL] [Abstract][Full Text] [Related]
2. Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial.
Hemida R; Vos EL; El-Deek B; Arafa M; Toson E; Burger CW; van Doorn HC
Obstet Gynecol; 2019 May; 133(5):1024-1031. PubMed ID: 30969220
[TBL] [Abstract][Full Text] [Related]
3. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
[TBL] [Abstract][Full Text] [Related]
4. Gestational Trophoblastic Neoplasia and Pregnancy Outcome After Routine Second Curettage for Hydatidiform Mole A Retrospective Observational Study.
Kan M; Yamamoto E; Niimi K; Tamakoshi K; Sekiya Y; Nishino K; Ino K; Kikkawa F
J Reprod Med; 2016 Aug; 61(7-8):373-379. PubMed ID: 30408385
[TBL] [Abstract][Full Text] [Related]
5. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
6. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
7. Second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Zhao P; Yu Y; Du M; Xu J; Lu W
Int J Gynaecol Obstet; 2024 Apr; 165(1):34-42. PubMed ID: 37753799
[TBL] [Abstract][Full Text] [Related]
8. Response: Second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Zhao P; Lu W
Int J Gynaecol Obstet; 2024 Jan; 164(1):375-376. PubMed ID: 37924216
[No Abstract] [Full Text] [Related]
9. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
10. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
[TBL] [Abstract][Full Text] [Related]
11. The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1).
McGrath S; Short D; Harvey R; Schmid P; Savage PM; Seckl MJ
Br J Cancer; 2010 Mar; 102(5):810-4. PubMed ID: 20160727
[TBL] [Abstract][Full Text] [Related]
12. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
13. Human Chorionic Gonadotropin Regression Curves after Partial or Complete Molar Pregnancy in Flanders: Are They Different from Regression Curves from the Eighties?
Delattre S; Han S; Moerman P; Billen J; Goffin F; Scharpé K; Vergote I
Gynecol Obstet Invest; 2018; 83(1):76-82. PubMed ID: 28329740
[TBL] [Abstract][Full Text] [Related]
14. Clinical response to a second uterine curettage in patients with low-risk gestational trophoblastic disease: a pilot study.
Yarandi F; Jafari F; Shojaei H; Izadi-Mood N
J Reprod Med; 2014; 59(11-12):566-70. PubMed ID: 25552129
[TBL] [Abstract][Full Text] [Related]
15. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.
Pezeshki M; Hancock BW; Silcocks P; Everard JE; Coleman J; Gillespie AM; Tidy J; Coleman RE
Gynecol Oncol; 2004 Dec; 95(3):423-9. PubMed ID: 15581942
[TBL] [Abstract][Full Text] [Related]
16. Experience of women on the Irish National Gestational Trophoblastic Disease Registry.
Joyce CM; Coulter J; Kenneally C; McCarthy TV; O'Donoghue K
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():206-212. PubMed ID: 35367922
[TBL] [Abstract][Full Text] [Related]
17. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
18. Surgery including fertility-sparing treatment of GTD.
Ngu SF; Ngan HYS
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():97-108. PubMed ID: 33127305
[TBL] [Abstract][Full Text] [Related]
19. Gestational trophoblastic neoplasia: does centralization of care impact clinical management?
Mitric C; Yang K; Bhat G; Lheureux S; Laframboise S; Li X; Bouchard-Fortier G
Int J Gynecol Cancer; 2023 Nov; 33(11):1724-1732. PubMed ID: 37723102
[TBL] [Abstract][Full Text] [Related]
20. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
